Insights+ Exclusive: COVID-19 Healthcare News Monthly Updates

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where we have covered news updates regarding collaborations, clinical trials, funding and regulatory guidelines related to the COVID-19 from Jan to date.

 

APRIL 2020

210. EIB To Provide Israel’s Pluristem with $54M For COVID-19 and Other Cell Therapies

Apr 30, 2020 | Grant

209. INOVIO Expands Manufacturing of INO-4800 With $1.3M Funding from CEPI

Apr 30, 2020 | Grant

208. EMA Initiates Rolling Review of Remdesivir for COVID-19

Apr 30, 2020 | Regulatory

207. EMA to Support Availability of Medicines Amid COVID-19

Apr 30, 2020 | Regulatory

206. Synairgen Receives Approval to Extend SG016 Clinical Study of SNG001 in Patients with COVID-19

Apr 30, 2020 | Clinical Trial

205. Calcimedica Expands Clinical Study to Evaluate CM4620-IE In Patients With Covid-19 Pneumonia On High-Flow Oxygen Therapy

Apr 30, 2020 | Clinical Trial

204. Integral Molecular Develops Test for Neutralizing AB in Patients with COVID-19

Apr 30, 2020 | Diagnostic

203. Pfizer to Develop 10-20M doses of vaccine By End of 2020

Apr 30, 2020 | Pharma

202. Global Pharma Accelerate the Development of New Treatments to Combat COVID-19

Apr 30, 2020 | Pharma

201. NICE Joins International Collaboratives to Combat COVID-19 Pandemic

Apr 30, 2020 | Collaboration

200. Mesoblast Commences the Enrollment in P-II/III Study of Remestemcel-L in Patients with COVID-19

Apr 30, 2020 | Clinical Trial

199. MUSC and HPE Make Innovative Drug Discovery Software Publicly Available In Response To Covid-19 Crisis

Apr 30, 2020 | DigiHealth

198. FUJIFILM Diosynth Biotechnologies to Reserve Manufacturing Capacity to Deliver COVID-19 Therapies

Apr 30, 2020 | Clinical Trial

197. ACAMP in Collaboration with University of Alberta Develops Plastic Respirators to Prevent Spread of Covid-19

Apr 29, 2020 | Collaboration

196. BIOTECON Diagnostics Launches Microproof kits for Covid-19

Apr 29, 2020 | Diagnostic

195. SeaStar Medical to Initiate a Study of Selective Cytopheretic Device in COVID-19 patients

Apr 29, 2020 | Clinical Trial

194. ERBA Mannheim Launches CE Marked COVID-19 Antibody ELISA Kits

Apr 29, 2020 | Diagnostic

193. Genalyte Reports Availability of its High-Speed COVID-19 Antibody Test

Apr 29, 2020 | Diagnostic

192. Accurate Diagnostic Labs Reports The Availability of Serological Antibody Test This Week

Apr 29, 2020 | Diagnostic

191. BioIQ and Matrix Medical Network Report the Availability of COVID-19 Testing Program for US Employers

Apr 29, 2020 | Diagnostic

190. IIT Guwahati collaborates with Hester Biosciences for Covid-19 Vaccine

Apr 29, 2020 | Collaboration

189. Montefiore and Albert Einstein College of Medicine Partner with NYU Langone Health to Determine if Convalescent Plasma can Treat COVID-19

Apr 29, 2020 | Collaboration

188. Chimerix Reports Initiation of a P-II/III Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19

Apr 29, 2020 | Clinical Trial

187. UQ Reports Preclinical Data of its COVID-19 Vaccine Candidate

Apr 29, 2020 | Clinical Trial

186. Verndari Initiates Preclinical Testing of COVID-19 Vaccine at University of California

Apr 29, 2020 | Clinical Trial

185. Treatments for COVID-19 Could Be Fast-Tracked Through New National Clinical Trial Initiative in the UK

Apr 29, 2020 | Regulatory

184. QLHC Collaborates with Sponsor of the Adaptive Platform I-Spy 2 Trial to Identify Therapies Targeting ARDS Associated with COVID-19

Apr 29, 2020 | Collaboration

183. BeiGene Collaborates with Atreca and IGM Biosciences to Develop Antibody Treatment Targeting COVID-19

Apr 29, 2020 | Collaboration

182. Formycon Initiates Antibody-Based Drug Development Against COVID-19

Apr 29, 2020 | Clinical Trial

181. Algernon Receives Health Canada Approval to Initiate P-IIb/III of Ifenprodil Against COVID-19  

Apr 29, 2020 | Clinical Trial

180. BioNTech and Pfizer Complete Dosing of BNT162 in First Cohort of P-I/II Study in Germany

Apr 29, 2020 | Clinical Trial

179. Novartis Plans to Commence P-III Clinical Study Evaluating Canakinumab for Patients with COVID-19 Pneumonia

Apr 28, 2020 | Clinical Trial

178. AIIMS Plans to Conduct Clinical Trial of Plasma Therapy Treating COVID-19

Apr 28, 2020 | Clinical Trial

177. Shionogi Facilitates the Development of Potential Treatments and Vaccine Against COVID-19

Apr 28, 2020 | Clinical Trial

176. Japan to Provide its Avigan to Thirty-Eight Countries As Early As This Week

Apr 28, 2020 | Grant

175. Secarna Pharmaceuticals Collaborate with Guangzhou’s Sun Yat-sen University to Develop a Treatment for COVID-19

Apr 28, 2020 | Collaboration

174.VistaGen Expands Clinical Development of PH94B to Include Adjustment Disorder Associated with COVID-19

Apr 28, 2020 | Clinical Trial

173. Sarepta Signs a Research Agreement with the US Department of Defense to Identify Antisense Oligonucleotides Against COVID-19

Apr 28, 2020 | Collaboration

172. The Serum Institute of India to Produce Millions of Potential Coronavirus Vaccine Doses

Apr 28, 2020 | Clinical Trial

171. PharmaMar Initiates Clinical Study with Aplidin For Potential Treatment Of COVID-19

Apr 28, 2020 | Clinical Trial

170. Global Pandemic Consortium Supports Trump’s Call for Evaluating UV Light as a Potential Treatment for COVID 19

Apr 28, 2020 | Collaboration

169. Invivoscribe Launches Diagnostic Test with an Option To Participate In SARS-CoV-2 Ab and Vaccine Program

Apr 28, 2020 | Diagnostic

168. Innate Pharma Reports First Patient Dosing of Avdoralimab in P-II Clinical Study in COVID-19 Patients With Severe Pneumonia

Apr 28, 2020 | Clinical Trial

167. Cromos Pharma Supports R-Pharm in Initiation of a Global Program to Test Olokizumab and RPH-104 in Patients with Severe COVID-19

Apr 28, 2020 | Clinical Trial

166. CEPI Collaborates with Clover to Support the Development of Vaccine Against COVID-19 in Australia

Apr 27, 2020 | Collaboration

165. ViiV Healthcare to Fund $3.24 to the Research Evaluating the Impact of COVID-19 on the HIV Community

Apr 27, 2020 | Grant

164. Innovation to Initiate the Testing of Brilacidin Against COVID-19 by the Week of May 4, 2020

Apr 27, 2020 | Clinical Trial

163. Kamada and Kedrion Biopharma Collaborate for Plasma-Derived Anti-SARS-CoV-2 Polyclonal Immunoglobulin Product

Apr 27, 2020 | Collaboration

162. HHS Launches COVID-19 Uninsured Program Portal

Apr 27, 2020 | DigiHealth

161. Mateon Reports Submission of IND to The US FDA for Evaluating Its OT-101 in Patients with COVID-19

Apr 27, 2020 | Clinical Trial

160. Romark to Initiate P-III Clinical Study Evaluating NT-300 For COVID-19

Apr 27, 2020 | Clinical Trial

159. Regeneron and Sanofi Provide Update of P-II/III Adaptive-Designed Trial of Kevzara in Hospitalized Patients with COVID-19 in the US

Apr 27, 2020 | Clinical Trial

158.  Capital Health Launches Antibody Testing Initiative for COVID-19

Apr 27, 2020 | Launch

157. Santhera Signs a Clinical Trial Agreement with Cold Spring Harbor Laboratory to Evaluate Lonodelestat (POL6014) Against Acute Respiratory Distress Syndrome Associated with COVID-19

Apr 27, 2020 | Clinical Trial

156. Kainos Medicine to Evaluate Compound Similar to Remdesivir as Treatment for COVID-19

Apr 26, 2020 | Clinical Trial

155. Serum Institute to Initiate Manufacturing of Oxford University’s COVID-19 Vaccine in Next 2-3 Weeks

Apr 25, 2020 | Clinical Trial

154. Wuhan Institute of Biological Products’ Inactivated COVID-19 Vaccine Enters In P-II Clinical Study

Apr 25, 2020 | Clinical Trial

153. UK Approves Clinical Study for Utilizing Plasma from Recovered Patients

Apr 25, 2020 | Clinical Trial

152. Biopharma to Initiate Clinical Study Evaluating Ab Against COVID-19 in Ukraine

Apr 24, 2020 | Clinical Trial

151. Global Leaders Collaborate to Make COVID-19 Testing and Treatment Available for All

Apr 24, 2020 | Collaboration

150. . WHO/Europe Publishes Considerations for Gradual Easing of Lockdown Restrictions across the European Region

Apr 24, 2020 | Regulatory

149. Janssen Collaborates with Emergent BioSolutions to Accelerate the Manufacturing of its Vaccine Against COVID-19

Apr 24, 2020 | Collaboration

148. Vela Diagnostics Receives CE mark for its ViroKey SARS-CoV-2 RT-PCR Test

Apr 24, 2020 | Diagnostic

147. ALung Receives the US FDA’s EUA for Hemolung Respiratory Assist System to Treat COVID-19

Apr 24, 2020 | Regulatory

146. Siemens Healthineers to Expand Sars-Cov-2 Testing to Include a Total Ab Test Targeting Covid-19 Pandemic

Apr 23, 2020 | Diagnostic

145. Enzo Biochem Launches Diagnostic Test for COVID-19 Under EUA

Apr 23, 2020 | Diagnostic

144. ReiThera Collaborates with Leukocare and Univercells to Fast-Track the Development of COVID-19 Vaccine

Apr 23, 2020 | Collaboration

143. NEC Publishes Design Blueprints for COVID-19 Vaccines Utilizing Artificial Intelligence

Apr 23, 2020 | DigiHealth

142. Arch Biopartners Reports Submission of Application to Health Canada for Conducting P-II Study of Metablok to Prevent Lung and Kidney Inflammation Associated with COVID19

Apr 23, 2020 | Regulatory

141. Human Vaccines Project Launches Global Initiative to Facilitate the Development of COVID-19 Vaccines

Apr 23, 2020 | Launch

140. NIH Unveils the Strategic Plan for Accelerating Research to Diagnose, Prevent and Treat COVID-19

Apr 23, 2020 | Regulatory

139. Insmed to Support Stop-Covid19 Study Evaluating Brensocatib (Formerly Ins1007) in Patients with Severe COVID-19

Apr 23, 2020 | Clinical Trial

138. ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research

Apr 23, 2020 | Clinical Trial

137. Cytovance Biologics and Akshaya Bio Announce Collaborate for Coronavirus And Hepatitis B Virus Infections

Apr 23, 2020 | Collaboration

136. Algernon Receives Regulatory and Ethics Approval for P-II Study Evaluating Ifenprodil for COVID-19 in South Korea

Apr 23, 2020 | Clinical Trial

135. Hemogenyx To Utilize Its Advanced Humanized Mice to Develop Potential Treatments for COVID-19

Apr 23, 2020 | Clinical Trial

134. NICE Publishes Two New Guidelines for COVID-19

Apr 23, 2020 | Regulatory

133. Swiss Hospitals Launches Clinical Study to Prevent Covid-19 Infection

Apr 23, 2020 | Clinical Trial

132. Theravance Reports First Patient Dosing in P-I Study with TD-0903 to Treat Patients with Acute Lung Injury Associated with COVID-19

Apr 23, 2020 | Clinical Trial

131. Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test in Finland

Apr 23, 2020 | Diagnostic

130. LabCorp Receives the US FDA’s Emergency Use Authorization for its COVID-19 At-Home Test Kit

Apr 23, 2020 | Diagnostic

129.  AstraZeneca and Saint Luke’s Mid America Heart Institute to Initiate P-III DARE-19 Evaluating Farxiga Against COVID-19

Apr 23, 2020 | Clinical Trial

128. Moleculin Reports Head of NIAID Antiviral Drug Discovery and Development Center Joins its COVID-19 Drug Development Team

Apr 22, 2020 | Pharma

127. Biovista Identified Four Treatment Against COVID-19 Utilizing its AI Platfrom

Apr 22, 2020 | Clinical Trial

126. Nuritas Deploys AI Platform to Identify Therapeutic Peptides Against COVID-19

Apr 22, 2020 | DigiHealth

125. Oncology Venture to Evaluate its 2X-121 as a Potential Therapy for COVID-19

Apr 22, 2020 | Clinical Trial

124. Precision For Medicine Collaborates with Karyopharm Therapeutics to Initiate Global Clinical Trial To Treat Patients with COVID-19

Apr 22, 2020 | Collaboration

123Valneva and Dynavax Collaborate to Advance the Development of Vaccine Against COVID-19

Apr 22, 2020 | Collaboration

122.  Pfizer and BioNTech to Commence Clinical Study for COVID-19 in Germany

Apr 22, 2020 | Clinical Trial

121. NIH Issues Guidelines for the Treatment of COVID-19

Apr 21, 2020 | Regulatory

120. Vivacelle Bio Reports the Compassionate Use of its VBI-S in Patients with COVID-19

Apr 21, 2020 | Regulatory

119. Edesa Biotech Sign License Agreement with Light Chain Bioscience to Develop Treatments for COVID-19 Pneumonia and Other Disorders

Apr 21, 2020 | Collaboration

118. First COVID-19 Patient Treated Under Emergency Use IND At Providence Saint John’s Health Center Using Stemedica Ischemia-Tolerant Allogeneic Mesenchymal Bone Marrow Cells

Apr 21, 2020 | Clinical Trial

117. RedHill Provides Update on the Compassionate Use of Opaganib in Patients with COVID-19 in Israel

Apr 21, 2020 | Regulatory

116. ChromaCode Launches High-Throughput HDPCR SARS-CoV-2 Assay to Detect COVID-19

Apr 21, 2020 | Launch

115. Kalos Report its Progress in Covid-19 Preventative & Therapeutic Approaches

Apr 21, 2020 | Clinical Trial

114. aTyr Pharma to Initiate P-II Study Evaluating ATYR1923 in COVID-19 Patients with Severe Respiratory Complications

Apr 21, 2020 | Clinical Trial

113. The Kingdom Saudi Arabia Pledges $150M to CEPI’s COVID-19 response

Apr 21, 2020 | Grants

112. Bonus Biogroup Initiates Preclinical Study to Treat Respiratory Distress in COVID-19 Patients

Apr 21, 2020 | Clinical Trial

111. RedHill Reports the US FDA’s Submission of Opaganib’s IND for COVID-19

Apr 21, 2020 | Regulatory

110. EMA Launches its Enhanced Monitoring System to Mitigate Supply Issues of Therapies USed in treating COVID-19

Apr 21, 2020 | DigiHealth

109. Hope Biosciences Reports its Third US FDA’s Approval for Clinical Trial in COVID-19

Apr 21, 2020 | Collaboration

108. Bayer Collaborates with the Population Health Research Institute to Identify Treatment for COVID-19

Apr 21, 2020 | Collaboration

107. Noxopharm Anticipates the US FDA’s Approval for Evaluating Veyonda in a Clinical Study for COVID-19

Apr 21, 2020 | Clinical Trial

106. RedHill Biopharma Collaborates with NIAID to Investigate RHB-107 (upamostat, WX-671) Against COVID-19

Apr 21, 2020 | Clinical Trial

105. OncoImmune Initiates P-III Clinical Study Evaluating CD24Fc in Dampening Inflammation Caused by Virus-Induced Cellular Injuries in Patients with Severe Covid-19

Apr 20, 2020 | Clinical Trial

104. The Massachusetts Institute of Technology Develops Open-Source Ventilator Addressing Shortage by Covid-19

Apr 20, 2020 | Pharma

103. Gilead’s Remdesivir Prevents Disease Progression in Monkeys with COVID-19

Apr 20, 2020 | Clinical Trial

102. Mint Pharmaceuticals Donates Hydroxychloroquine to St. Joseph’s Healthcare Hamilton Clinical Study to Prevent COVID-19 Amongst Front Line Healthcare Workers and Early Treatment of Mild Cases

Apr 20, 2020 | Grants

101. Genedrive and Cytiva Collaborate to develop PCR assay for COVID-19

Apr 20, 2020 | Collaboration

100. Vela Diagnostics Receives BARDA Funding to Develop Tests for COVID-19

Apr 20, 2020 | Grants

99. AIkido Pharma Signs Licensing Agreement with University of Maryland for Antiviral Therapies Including COVID-19

Apr 20, 2020 | Collaboration

98.  Alexion to Initiate P-III Study of Ultomiris (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19

Apr 20, 2020 | Clinical Trial

97. Incyte Initiates P-III RUXCOVID Study Evaluating Jakafi (ruxolitinib) to Treat Patients with COVID-19 Associated Cytokine Storm

Apr 20, 2020 | Clinical Trial

96.  Fosun Pharma Receives the US FDA’s EUA for its COVID-19 RT-PCR Detection Kit

Apr 20, 2020 | Diagnostic

95.  Novartis Signs an Agreement with the US FDA to Evaluate Hydroxychloroquine in Patients with COVID-19

Apr 20, 2020 | Collaboration

94. UNICEF and Microsoft Launch Global Learning Platform to Address COVID-19 Education Crisis

Apr 19, 2020 | Diagnostic

93.  BARDA Grants ~ $483M to Moderna for Accelerating the Development of mRNA-1273 Against COVID-19

Apr 17, 2020 | Grant

92. Roche Develops Elecsys Anti-SARS-CoV-2 Serology Test to Detect Ab Against COVID-19

Apr 17, 2020 | Diagnostic

91. Sanofi and Luminostics Collaborate to Develop Smartphone-Based Self-Testing Solution for COVID-19

Apr 17, 2020 | DigiHealth

90. 1Health.io Launches Self-Collection Kits to Detect Covid-19

Apr 17, 2020 | Diagnostic

89.  Sinovac Initiates the P-I Clinical Study for Vaccine Candidate Against COVID-19

Apr 17, 2020 | Clinical Trial

88. Karolinska Development’s Portfolio Company Dilafor Collaborates with Liverpool University to Evaluate Tafoxiparin Against COVID-19

Apr 17, 2020 | Collaboration

87. NIH Unveils Public-Private Collaboration to Accelerate COVID-19 Vaccine and Treatment Options

Apr 17, 2020 | Collaboration

86. Enterin to Conduct P-I/IIa Study Evaluating COV-ENT-1 in Hospitalized Patients With COVID-19

Apr 17, 2020 | Clinical Trial

85. NIH Enrolls Older Adults in a Clinical Study of Vaccine for COVID-19

Apr 17, 2020 | Clinical Trial

84. Gilead Increases Enrollment Target for Clinical Study Evaluating Remdesivir in Patients with COVID-19

Apr 17, 2020 | Clinical Trial

83. Oncolytics Provides Updates on its Clinical Development and Operations Activities Amid COVID-19 Pandemic

Apr 17, 2020 | Pharma

82.  Dynavax Signs an Agreement with Sinovac to Develop a Vaccine for COVID-19

Apr 16, 2020 | Collaboration

81.  Novavax Signs a Clinical Trial Agreement with Nucleus Network to Initiate the Clinical Study Evaluating NVX-CoV2373 Against COVID-19

Apr 16, 2020 | Clinical Trial

80. BeiGene to Initiate Clinical Study Evaluating Brukinsa In Later-Stage COVID-19 Patients

Apr 16, 2020 | Clinical Trial

79. Vanda Collaborates with Northwell Health to Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia

Apr 16, 2020 | Clinical Trial

78. FairJourney Biologics and Iontas Collaborate to Identify Effective Treatment for COVID-19

Apr 16, 2020 | Collaboration

77. Omega Diagnostics Signs MoU With Three Companies to Develop Covid-19 Test in the UK

Apr 15, 2020 | Collaboration

76.   Vanda Collaborates with Northwell Health to Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia

Apr 15, 2020 | Clinical Trial

75. Humanigen Receives FDA’s Approval to Initiate P-III Study of Lenzilumab in COVID-19 Patients

Apr 15, 2020 | Clinical Trial

74.  Flow Pharma Partnered with Oakwood Labs for GMP Manufacturing of FlowVax COVID-19 Vaccine

Apr 15, 2020 | Collaboration

73. Ginkgo Supports Moderna on Process Optimization for COVID-19

Apr 15, 2020 | Grant

72.  HALIX Partnered with University of Oxford for GMP Manufacturing of a COVID-19 Vaccine

Apr 15, 2020 | Collaboration

71.  Bold Therapeutics and the University of Ottawa Collaborate Evaluate BOLD-100 Against COVID-19

Apr 15, 2020 | Clinical Trial

70.  Applied DNA Supplies COVID-19 LinearDNA Vaccine Candidates to Takis to Initiate Preclinical Testing

Apr 15, 2020 | Clinical Trial

69. India to Sell Hydroxychloroquine to Malaysia for Combating COVID-19

Apr 15, 2020 | Collaboration

68.  Fujifilm Facilitates the Production of its Avigan for COVID-19

Apr 15, 2020 | Clinical Trial

67.  Vanda Signs a Collaboration with UW Medicine to Initiate CALYPSO Program for Evaluating the Role of Genetic Variation in COVID-19

Apr 15, 2020 | Collaboration

66.  GE Healthcare and Microsoft Exploit Remote Patient Data Monitoring Technology to Support Clinicians for the Treatment of COVID-19

Apr 15, 2020 | DigiHealth

65.   Abbott Launches its Third Test to Detect COVID-19

Apr 15, 2020 | Diagnostic

64.  AstraZeneca Initiates CALAVI Study Evaluating Calquence (acalabrutinib) Against COVID-19

Apr 14, 2020 | Clinical Trial

63. Sosei Heptares to Utilize its Structure- Based Drug Design Expertise in New COVID-19 R&D Program

Apr 14, 2020 | Clinical Trial

62. Ortho Clinical Diagnostics Receives the US FDA’s Emergency Use Authorization for its Total Antibody Test for COVID-19

Apr 14, 2020 | Diagnostic

61.KD Pharma Group & SLA Pharma Initiate Clinical Study Evaluating EPAspire Against COVID-19

Apr 14, 2020 | Clinical Trial

60. Sanofi and GSK Collaborate to Develop Adjuvanted COVID-19 Vaccine

Apr 14, 2020 | Collaboration

59. BD Receives Second FDA’s Emergency Use Authorization for its New Molecular Diagnostic Test to Detect COVID-19

Apr 13, 2020 | Diagnostic

58. Celltrion Anticipates the Initiation of its First-in-Human Clinical Studies Targeting COVID-19 in July

Apr 13, 2020 | Clinical Trial

57. Pluristem Therapeutics Treats First COVID-19 Patient in the US Under FDA Single Patient Expanded Access Program

Apr 13, 2020 | Clinical Trial

56. Rutgers’ Saliva Test Receives the US FDA’s Approval to Detect COVID-19

Apr 13, 2020 | Diagnostics

55. Stanford Utilizes Digital Tools to Predict the Next Covid-19 Surge

Apr 13, 2020 | DigiHealth

54. The US FDA Approves Decontamination of N95 Respirator For Reuse

Apr 13, 2020 | Regulatory

53. Bausch Health to Initiate Clinical Study Evaluating Virazole (Ribavirin for Inhalation Solution, USP) in Patients with COVID-19 in Canada

Apr 13, 2020 | Clinical Trial

52. NextCure Delays Clinical Studies Evaluating NC318 and NC410 Amid COVID-19

Apr 13, 2020 | Clinical Trial

52. Sanofi to Donate 100M Doses of Hydroxychloroquine Across 50 Countries 

Apr 10, 2020 | Grant

51. Apple and Google Collaborate on Contact Tracing Technology to Combat COVID-19

Apr 10, 2020 | DigiHealth

50. Eli Lilly Signs a Clinical Trial Collaboration with NIH to Evaluate Baricitinib Against COVID-19

Apr 10, 2020 | Collaboration

49. Terumo BCT and Marker Therapeutics Receive the US FDA’s Emergency Use Authorization for their Purification Device to Treat COVID-19

Apr 10, 2020 | Regulatory

48. Amgen Signs a Partnership with Adaptive Biotecnologies to Develop Abs for COVID-19

Apr 10, 2020 | Collaboration

46. Samsung Biologics Signs an Agreement with Vir Biotechnology to Develop Abs for COVID-19

Apr 10, 2020 | Collaboration

47. Initiates Clinical Study to Evaluate Galidesivir for Treatment of Patients with COVID-19

Apr 09, 2020 | Clinical Trial

46.  Zentiva and IKEA Collaborate to Fight the COVID-19 Pandemic

Apr 09, 2020 | Collaboration

45.  Pfizer and BioNTech Provide Updates on its Collaboration for Global Covid-19 Vaccine

Apr 09, 2020 | Collaboration

44.   AstraZeneca Focuses on the Discovery of Monoclonal Antibodies Neutralizing SARS-CoV-2 Virus

Apr 08, 2020 | Clinical Trial

43.  Chugai Initiates P-III Clinical Study of Actemra for COVID-19 Pneumonia in Japan

Apr 08, 2020 | Clinical Trial

42.  Novavax Accelerates the Initiation of Clinical Study for NVX-CoV2373 to Mid-May 2020

Apr 08, 2020 | Clinical Trial

41.   Global Pharmaceuticals and the University of Cambridge Collaborate to Launch a Laboratory for COVID-19 Testing

Apr 08, 2020 | Launch

40. Automation Anywhere Launches New RPA Solutions Amid Global COVID-19 Pandemic

Apr 08, 2020 | Digihealth

39.  Vanda Pharmaceuticals and The University of Illinois Collaborate To Identify Novel Antivirals Against COVID-19

Apr 08, 2020 | Collaboration

38.   Oxford Biomedica Joins Consortium to Develop ChAdOx1 nCov-19 for COVID-19

Apr 08, 2020 | Collaboration

37. Vertex to Donate $5M for Supporting Global COVID-19 Pandemic

Apr 07, 2020 | Grant

36.  BMS Expands its Existing Patient Support Programs to Aid Uninsured Patients in the US Amid COVID-19

Apr 07, 2020 | Pharma

35.  Bio-Rad Launch a Serology Assay to Detect COVID-19 Antibodies

Apr 07, 2020 | Diagnostics

35.  Lupus and its Affiliate of Research Alliance Commencing a Study Targeting Lupus Patients and COVID-19

Apr 07, 2020 | Clinical Trial

34.  Ridgeback Biotherapeutics to Initiate the Clinical Development EIDD-2801 for COVID-19

Apr 07, 2020 | Clinical Trial

33.  Eli Lilly Offers $35 Insulin Copay in the US Amid COVID19

Apr 07, 2020 | Pharma

32.  CytoDyn Collaborates with UK’s Department of Health to Provide Emergency Access to Leronlimab (PRO 140) for Patients with COVID-19

Apr 07, 2020 | Collaboration

31.  Global Plasma Leaders Collaborate to Expedite the Development of COVID-19 Hyperimmune Therapy

Apr 06, 2020 | Collaboration

30. GSK Collaborates with Vir to Develop Treatment for COVID-19

Apr 06, 2020 | Collaboration

29.  Co-Diagnostics Receives The US FDA’s Emergency Use Authorization for its COVID-19 Test

Apr 06, 2020 | Diagnostic

28.  BGI and AID Genomics Collaborate to Establish COVID-19 Testing Lab in Gaza

Apr 06, 2020 | Collaboration

27.  EMA’s CHMP Recommends Compassionate Use of Gilead’s Remdesivir for COVID-19

Apr 06, 2020 | Regulatory

26.  GSK Collaborates with Innovax to Evaluate a Vaccine Against COVID-19 Pandemic

Apr 06, 2020 | Collaboration

25.   Pfizer And The Pfizer Foundation Donate $40M to Combat COVID-19 Pandemic

Apr 06, 2020 | Grant

24.  WHO and UNICEF Collaborate on Pandemic Response Through COVID-19 Solidarity Response Fund

Apr 04, 2020 | Regulatory

23.  NICE Publishes 4 New Rapid Guidelines to Manage COVID-19

Apr 04, 2020 | Regulatory

22.  ForaCare Suisse Launches Autonomous Temperature Measuring Station to Assist in COVID-19 Pandemic

Apr 03, 2020 | Launch

21.  Cassia Networks Partners with VivaLNK to Combat COVID-19 in China

Apr 03, 2020 | Collaboration

20. Babylon Health Launches Covid-19 Symptom Tracker

Apr 03, 2020 | Digi Health

19.  Siemens Healthineers Launches Test Kit for COVID-19

Apr 03, 2020 | Diagnostic

18.  Leica Biosystems Receives FDA’s Enforcement Discretion For its Aperio ImageScope DX Viewing Software Used For Remote Diagnosis Amid COVID-19

Apr 03, 2020 | Digi Health

17.  BD and BioGX Receive the US FDA’s Emergency Use Authorization for its COVID-19 Test

Apr 03, 2020 | Diagnostic

16.  I-Mab to Initiate Clinical Study for TJM2 for CRS Associated with COVID-19 Following FDA’s IND Approval

Apr 03, 2020 | Clinical Trial

15.   XBiotech and BioBridge Global Collaborate on FDA Program to Develop Therapies Targeting COVID-19

Apr 03, 2020 | Collaboration

14.   Novartis Donates Hydroxychloroquine to Treat Hospitalized COVID-19 Patients in Switzerland

Apr 03, 2020 | Grant

13.  Celltrion Enters the Next Phase of Development for its Antiviral Therapy to Combat COVID-19 Pandemic

Apr 03, 2020 | Clinical Trial

12.  Sorrento Initiates the Next Phase of its Collaboration with Celularity

Apr 02, 2020 | Collaboration

11.   Emergent BioSolutions Collaborates with US Government for Comprehensive Response to Expedite the Development of Plasma-Derived Therapy for COVID-19

Apr 02, 2020 | Collaboration

10.  Celularity’s New Cell Therapy Receives the US FDA’s IND Approval for COVID-19

Apr 02, 2020 | Clinical Trial

9.   Amgen and Adaptive Biotechnologies Collaborate to Develop Therapies Targeting COVID-19

Apr 02, 2020 | Collaboration

8.  Novartis and Incyte Intend to Initiate the P-III RUXCOVID Study of Jakavi (ruxolitinib) as a Treatment for Patients with COVID-19 Associated Cytokine Storm

Apr 02, 2020 | Clinical Trial

7.  Vir and Alnylam Expand Their Existing Collaboration to Develop RNAi Therapeutics Targeting Host Factors for COVID-19

Apr 02, 2020 | Collaboration

6. Affimed Provides Update on its Business Amid COVID-19

Apr 02, 2020 | Pharma

5. ImmunityBio and Microsoft Collaborate to Create 3D model of Covid-19’s Spike Protein Leveraging Azure Platform

Apr 01, 2020 | DigiHealth

4.  Cardiovascular Systems Withdraws its 2020 Guidance Amid COVID-19

Apr 01, 2020 | Regulatory

3.  Boston Scientific Withdraws Guidance Due to COVID-19

Apr 01, 2020 | Regulatory

2.  Three Global Pharmaceutical Companies Launch Worker Volunteer Programs to Combat COVID-19

Apr 01, 2020 | Launch

1. FDA Launches Emergency Program to Expedite the Development of COVID-19 Treatments 

Apr 01, 2020 | Regulatory

Related Article: Insights+ Exclusive: COVID-19 Healthcare News Updates (March)